The validity of the SF-12 and SF-6D instruments in people living with HIV/AIDS in Kenya.

Journal: Health and quality of life outcomes

Volume: 15

Issue: 1

Year of Publication: 2017

Affiliated Institutions:  Department of Medicine, University of British Columbia, West th Avenue, Vancouver, BC, VZ M, Canada. anikpa@mail.ubc.ca. Department of Medicine, University of British Columbia, West th Avenue, Vancouver, BC, VZ M, Canada. School of Pharmacy, University of Otago, Dunedin, New Zealand. School of Kinesiology & Health Sciences, York University, Campus Walk, North York, ON, MJ P, Canada. Faculty of Health Sciences, Simon Fraser University, University Drive, Burnaby, BC, VA S, Canada. Monitoring, Evaluation and Research Unit, Amref Health Africa in Kenya, P.O. Box -, Nairobi, Kenya. Faculty of Pharmaceutical Science, University of British Columbia, Westbrook Mall, Vancouver, Canada.

Abstract summary 

Health-related quality of life (HRQoL) and health state utility value (HSUV) measurements are vital components of healthcare clinical and economic evaluations. Accurate measurement of HSUV and HRQoL require validated instruments. The 12-item Short-Form Health Survey (SF-12) is one of few instruments that can evaluate both HRQoL and HSUV, but its validity has not been assessed in people living with HIV/AIDS (PLWHA) in east Africa, where the burden of HIV is high.This cross-sectional study used baseline data from a randomized trial involving PLWHA in Kenya. Data included responses from a translated and adapted SF-12 survey as well as key demographic and clinical data. Construct validity of the survey was examined by testing the SF-12's ability to distinguish between groups known in advance to have differences in their health based on their disease severity. We classified disease severity based on established definitions from the US Center for Disease Control (CDC) and WHO, as well as a previously studied viral load threshold. T-tests and ANOVA were used to test for differences in HRQoL and HSUV scores. Area under the receive operator curve (AUC) was used to test the discriminative ability of the HRQoL and HSUV instruments.Differences in physical component scores met the minimum clinically important difference among participants with more advanced HIV when defined by CD4 count (4.3 units) and WHO criteria (compared to stage 1, stages 2, 3 and 4 were 2.0, 7.2 and 9.8 units lower respectively). Mental score differences met the minimum clinically important difference between WHO stage 1 and stage 4 patients (4.4). Differences in the HSUV were statistically lower in more advanced HIV by all three definitions of severity. The AUC showed poor to weak discriminatory ability in most analyses, but had fair discriminatory ability between WHO clinical stage 1 and clinical stage 4 individuals (AUC = 0.71).Our findings suggest that the Kiswahili translated and adapted version of the SF-12 could be used as an assessment tool for physical health, mental health and HSUV for Kiswahili-speaking PLHWA.Clinical trials.gov identifier: NCT00830622 . Registered 26 January 2009.

Authors & Co-authors:  Patel Lester Marra van der Kop Ritvo Engel Karanja Lynd

Study Outcome 

Source Link: Visit source

Statistics
Citations :  Brazier JE, Roberts J. The estimation of a preference-based measure of health from the SF-12. Med Care. 2004;42:851–859. doi: 10.1097/01.mlr.0000135827.18610.0d.
Authors :  8
Identifiers
Doi : 143
SSN : 1477-7525
Study Population
Male,Female
Mesh Terms
Acquired Immunodeficiency Syndrome
Other Terms
HIV;Health state utility;Kiswahili;Quality of life;SF6D;Short-form 12
Study Design
Study Approach
Country of Study
Kenya
Publication Country
England